Shareholders meeting

Date: 10th July 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street, Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001 Scrip Symbol- SUDEEPPHRM Scrip Code: 544619 Sub: Notice of 37th Annual General Meeting Ref: Regulation 30 and 34 of the SEBI (LODR) Regulations, 2015 (Listing Regulations) Dear Sir/Madam, Notice of the 37th Annual General Meeting for the members of the Company is attached herewith. The Schedule for the Annual General Meeting is as follows: Annual General Meeting : 37th Day & Date : Tuesday, 4th August 2026 Time : 11:00 A.M. Mode : Through Video Conferencing (“VC”/ Other Audio-Visual Means) (“OAVM”) Further, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended, and Regulation 44 of the Listing Regulations, we wish to inform you that the Company is providing e-Voting facility to the Members of the Company to cast their votes by electronic means on all the resolutions set out in the Notice of AGM through the e-Voting services provided by National Securities Depository Limited (NSDL). Cut-off day for determining Tuesday, 28th July 2026 the eligibility of Members to : vote by e-Voting for the AGM E-voting Starting Day, date : Saturday, 1st August 2026 and time 09:00 a.m. E-voting Ending Day, date and : Monday, 3rd August 2026 time 05:00 p.m. The Notice convening the 37th AGM is being dispatched electronically to those Members whose email IDs are registered with the Company/ MUFG Intime India Private Limited ("Registrar and Transfer Agents" of the Company) and/or the Depository Participant(s) and the said Notice is also available on the website of the Company at https://www.sudeeppharma.com/ under 'Investor Relations' section. CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Further, pursuant to Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company has sent a letter providing a web-link of the Integrated Annual Report 2025-26 to those Members who have not registered their e-mail addresses with the Company/Depositories. The Integrated Annual Report containing the AGM Notice for Financial Year 2025-26 is also uploaded on the Company’s website viz. https://www.sudeeppharma.com/ Kindly take note of the same. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 ENCL: A/a CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com Statutory Reports Notice NOTICE is hereby given that the 37th Annual General Meeting (AGM) of the Shareholders of Sudeep Pharma Limited (‘the Company’) (CIN: L24231GJ1989PLC013141) will be held on Tuesday, 4th August, 2026 at 11:00 a.m. (IST) through Video Conferencing (“VC”)/Other Audio-Visual Means (“OAVM”) to transact the following businesses: ORDINARY BUSINESSES: “ RESOLVED THAT a Dividend of `1.50/- (Rupees One and fifty paisa only) being (150%) per Equity Share of 1. To receive, consider and adopt the Audited the face value of `1/- each for the Financial Year ended Standalone and Consolidated Financial Statements 31st March, 2026 on Equity Shares of the Company as of the Company for the Financial Year ended 31st recommended by the Board of Directors and the same March, 2026 together with the Reports of the Board of be paid out of the profits of the Company”. Directors and Auditors thereon. To consider and if thought fit, to pass, with or without SPECIAL BUSINESSES: modification(s), the following resolution as an Ordinary 4. Ratification of remuneration to be paid to Cost Resolution: Auditors for FY 2026-27. “RESOLVED THAT the Audited Standalone and To consider and if thought fit, to pass, with or without Consolidated Financial Statements of the Company, modification(s) the following resolution as an Ordinary including Balance Sheet as of 31st March, 2026 and Resolution: the Statement of Profit and Loss for the financial year ended on that date together with Cash Flow Statement “RESOLVED THAT pursuant to the provisions of and notes attached thereto, Auditor’s Report and Section 148 and all other applicable provisions, if any, Report of Board of Directors thereon be and are hereby of the Companies Act, 2013 and the Companies (Audit received, considered and adopted”. and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof, for the 2. Re-appointment of Mr Ajay Shrirang Kandelkar (DIN: time being in force), M/s. Chetan Gandhi & Associates, 10773491) as a director, who retires by rotation and Cost Accountants, Vadodara, a proprietary firm, having being eligible, offers himself for re-appointment. Membership No. 22096 and Firm Registration No. Explanation: Based on the terms of appointment, 101341, appointed by the Board of Directors of the executive, non-executive directors and non- Company, to conduct the audit of the cost records of independent chairman are subject to retirement by the Company for the Financial Year ending 31st March, rotation. Mr Ajay Shrirang Kandelkar, who was initially 2027, be paid remuneration not exceeding `50,000/- appointed on 13th September, 2024 whose office is liable (Rupees Fifty Thousand Only) plus applicable GST and to retire by rotation at this AGM, being eligible, offers out of pocket expenses. himself for re-appointment at the ensuing AGM, being RESOLVED FURTHER THAT the Key Managerial eligible, seeks re-appointment. Based on performance Personnel of the Company, be and are hereby severally evaluation and the recommendation of the nomination authorised to do all the acts, deeds, matters and and remuneration committee, the Board recommends things necessary and expedient to give effect to this his re-appointment. resolution.” To consider and if thought fit, to pass, with or without 5. To Appoint Mr. Hemang Mehta, a proprietor of H. modification(s), the following resolution as an Ordinary M. Mehta & Associates, Peer reviewed Practicing Resolution: Company Secretary, as Secretarial Auditor of the “RESOLVED THAT pursuant to the provisions of Section Company for a term of 5 (Five) consecutive years and 152(6) and other applicable provisions, if any, of the fix their remuneration.: Companies Act, 2013, the approval of members of the To consider and, if thought fit, to pass, with or without Company, be and is hereby accorded to re-appoint Mr modification(s), the following resolution as an Ordinary Ajay Shrirang Kandelkar (DIN: 10773491) as a director Resolution: of the Company, who retires by rotation at this Annual General Meeting and being eligible, offered himself for “RESOLVED THAT pursuant to the provisions of re-appointment”. Section 204 and all other applicable provisions of the Companies Act, 2013, read with the Companies 3. To declare dividend on equity shares for the (Appointment and Remuneration of Managerial FY 2025-26: Personnel) Rules, 2014 and Regulation 24A and other To consider and, if thought fit, to pass, with or without applicable provisions of the Securities and Exchange modification(s), the following resolution as an Ordinary Board of India (Listing Obligations and Disclosure Resolution: Delivering Products That Matter Annual Report - 2025-26 Notice (Contd.) Requirements) Regulations, 2015 (Listing Regulations), SPECIAL RESOLUTIONS: as amended from time to time (including any statutory 7. To ratify ‘Sudeep Pharm [Showing first 8,000 characters — download PDF for full document]